Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellderm Technologies was a Canadian private healthcare and natural products company focused on research, development, and commercialization of natural health products for pain management, immune dysfunction, and wellness. The company described itself as developing highly purified botanical extracts and held rights to the proprietary Ligna-Plex process and related products marketed for immune enhancement and antiviral, antibacterial, and anticancer activity. Publicly visible product and trademark evidence points to a portfolio that included LehCare, DermaPatch, Immunophen, and LignaPlex-branded offerings. The company appears to have operated from the White Rock/Surrey area of British Columbia and is listed by Crunchbase as permanently closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellderm Technologies.